Kamikihito ameliorates tumor-induced sickness behavior in mice

Traditional and Kampo Medicine

Volumn 2, Issue 2, 2015, Pages 93-96

  Araki, Ryota ^a   Nishida, Shoji ^a   Hiraki, Yosuke ^a   Yabe, Takeshi ^a  

^a SETSUNAN UNIVERSITY   (Japan)

Author keywords

colon 26; depression like behavior; kamikihito; sickness behavior; social interaction; tumor

Indexed keywords

KAMIKIHITO; KAMIKIHITO EXTRACT; KAMPO; MILNACIPRAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; BEHAVIOR CHANGE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; EMOTION; EXPLORATORY BEHAVIOR; EXPLORATORY BEHAVIOR TEST; FORCED SWIM TEST; GINSENG; ILLNESS BEHAVIOR; IMMOBILITY; INFLAMMATORY DISEASE; MALE; MALIGNANT NEOPLASM; MC-26 CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOCIAL INTERACTION; SOCIAL INTERACTION TEST; TUMOR GROWTH; TUMOR INDUCED SICKNESS BEHAVIOR;

EID: 84994409301     PISSN: None     EISSN: 20534515     Source Type: Journal    
DOI: 10.1002/tkm2.1025     Document Type: Article

References (15)

1. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008; 9: 46–56.
2. DellaGioia N, Hannestad J. A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci. Biobehav. Rev. 2010; 34: 130–143.
3. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am. J. Psychiatry 2000; 157: 683–694.
4. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 1996; 711: 163–174.
5. Haba R, Shintani N, Onaka Y et al. Central CRTH2, a second prostaglandin D2 receptor, mediates emotional impairment in the lipopolysaccharide and tumor-induced sickness behavior model. J. Neurosci. 2014; 34: 2514–2523.
6. Egashira N, Manome N, Kurauchi K et al. Kamikihi-to, a Kampo medicine, ameliorates impairment of spatial memory in rats. Phytother. Res. 2007; 21: 126–129.
7. Tohda C, Nakada R, Urano T, Okonogi A, Kuboyama T. Kamikihi-to (KKT) rescues axonal and synaptic degeneration associated with memory impairment in a mouse model of Alzheimer's disease, 5XFAD. Int. J. Neurosci. 2011; 121: 641–648.
8. Nishizawa K, Saito H, Nishiyama N. Effects of Kamikihi-To, a traditional Chinese medicine, on passive and conditioned avoidance performance impairment in senescence accelerated mouse (SAM). Jpn. J. Pharmacol. 1990; 54: 375–382.
9. Shimamura M, Nishizawa K, Yamashita A. Effects of kamikihi-to on ovariectomy-induced changes in behavior and circulation in rats. Nihon Yakurigaku Zasshi 1996; 108: 65–75.
10. Nishizawa K, Yamashita A. Effects of Kamikihi-To, a traditional Chinese medicine, on behavioral changes induced by methyl-beta-carboline-3-carboxylate in mice and rats. Jpn. J. Pharmacol. 1997; 75: 391–397.
11. Haba R, Shintani N, Onaka Y et al. Lipopolysaccharide affects exploratory behaviors toward novel objects by impairing cognition and/or motivation in mice: possible role of activation of the central amygdala. Behav. Brain Res. 2012; 228: 423–431.
12. Yamaguchi K, Kido H, Kawakatsu T et al. Effects of kami-kihi-to (jia-wei-gui-pi-tang) on autoantibodies in patients with chronic immune thrombocytopenic purpura. Am. J. Chin. Med. 1993; 21: 251–255.
13. Hirano A, Ueoka H. Successful treatment of an elderly patient with idiopathic thrombocytopenic purpura accompanied with chronic subdural hematoma, using a Chinese herbal medicine, EK-49, and ascorbic acid. Nihon Ronen Igakkai Zasshi 2001; 38: 224–228.
14. Cleeland CS, Bennett GJ, Dantzer R et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003; 97: 2919–2925.
15. Myers JS. Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms. Oncol. Nurs. Forum 2008; 35: 802–807.